Neurology Central

Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management


Background: Conventional and PEGylated liposomes were developed, aimed at improving the pain-killing effect of opiorphin. Methods: The antinociceptive action of the formulations was investigated on rats (tail-flick test), and compared with that of opiorphin and morphine aqueous solutions (all at 5 mg/kg). Results: Opiorphin loading in conventional liposomes enabled a 28% AUC increase with respect to free peptide.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.